• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种风险预测工具,以识别吸毒者中更有可能患有丙型肝炎的人群。

Development and Validation of a Risk Prediction Tool to Identify People at Greater Risk of Having Hepatitis C among Drug Users.

机构信息

Medical School of Ningbo University, Ningbo University, Ningbo 315211, China.

Department of AIDS and STDs Prevention and Control, Zhejiang Province Center for Disease Control and Prevention, Hangzhou 310051, China.

出版信息

Int J Environ Res Public Health. 2022 Nov 25;19(23):15677. doi: 10.3390/ijerph192315677.

DOI:10.3390/ijerph192315677
PMID:36497751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9738321/
Abstract

BACKGROUND

People who use drugs (PWUD) are among those with the highest risk for hepatitis C virus (HCV) infection. Highly effective direct-acting antiviral agents offer an opportunity to eliminate HCV. A simple tool for the prediction of HCV infection risk in PWUD is urgently needed. This study aimed to develop and validate a risk prediction tool to identify people at greater risk of having hepatitis C among PWUD that is applicable in resource-limited settings.

METHODS

We extracted data from national HIV/AIDS sentinel surveillance in PWUD (Zhejiang Province, 2016-2021) and developed and validated a risk score to improve HCV testing in PWUD. This risk score consists of seven risk factors identified using multivariable logistic regression modeling (2016-2020, exploratory group). We validated this score using surveillance data for 2021 (validation group). The accuracy of the model was determined using C-statistics.

RESULTS

We identified seven risk factors, including sex, age, marital status, educational attainment, and the use of heroin, morphine, and methamphetamine. In the exploratory group, the positive rates of detecting the HCV antibody in the low-risk (0-9 points), intermediate-risk (10-16 points), and high-risk (≥17 points) groups were 6.72%, 17.24%, and 38.02%, respectively ( < 0.001). In the validation group, the positive rates in the low-, medium-, and high-risk groups were 4.46%, 12.23%, and 38.99%, respectively ( < 0.001).

CONCLUSIONS

We developed and validated a drug-specific risk prediction tool for identifying PWUD at increased risk of HCV infection. This tool can complement and integrate the screening strategy for the purpose of early diagnosis and treatment.

摘要

背景

吸毒人群(PWUD)是丙型肝炎病毒(HCV)感染风险最高的人群之一。高效的直接作用抗病毒药物为消除 HCV 提供了机会。因此,迫切需要一种用于预测 PWUD 中 HCV 感染风险的简单工具。本研究旨在开发和验证一种风险预测工具,以识别 PWUD 中具有更高 HCV 感染风险的人群,该工具适用于资源有限的环境。

方法

我们从全国 HIV/AIDS 哨点监测中提取了 PWUD(浙江省,2016-2021 年)的数据,并开发和验证了一种风险评分,以提高 PWUD 中的 HCV 检测率。该风险评分由通过多变量逻辑回归建模确定的七个风险因素组成(2016-2020 年,探索性组)。我们使用 2021 年的监测数据对该评分进行了验证(验证组)。使用 C 统计量确定模型的准确性。

结果

我们确定了七个风险因素,包括性别、年龄、婚姻状况、受教育程度以及海洛因、吗啡和甲基苯丙胺的使用。在探索性组中,低风险(0-9 分)、中风险(10-16 分)和高风险(≥17 分)组 HCV 抗体检测的阳性率分别为 6.72%、17.24%和 38.02%(<0.001)。在验证组中,低、中、高风险组的阳性率分别为 4.46%、12.23%和 38.99%(<0.001)。

结论

我们开发并验证了一种针对特定药物的风险预测工具,用于识别 HCV 感染风险增加的 PWUD。该工具可以补充和整合筛查策略,以实现早期诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ca/9738321/5ac2ff468c9f/ijerph-19-15677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ca/9738321/db69ccc8c11a/ijerph-19-15677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ca/9738321/5ac2ff468c9f/ijerph-19-15677-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ca/9738321/db69ccc8c11a/ijerph-19-15677-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ca/9738321/5ac2ff468c9f/ijerph-19-15677-g002.jpg

相似文献

1
Development and Validation of a Risk Prediction Tool to Identify People at Greater Risk of Having Hepatitis C among Drug Users.开发和验证一种风险预测工具,以识别吸毒者中更有可能患有丙型肝炎的人群。
Int J Environ Res Public Health. 2022 Nov 25;19(23):15677. doi: 10.3390/ijerph192315677.
2
On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era.现场检测和病例管理以改善 DAA 时代药物使用者的丙型肝炎护理:一项前瞻性、纵向、多中心研究。
BMC Public Health. 2021 Aug 20;21(1):1574. doi: 10.1186/s12889-021-11608-9.
3
Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).南非获取艾滋病毒预防、治疗和相关服务的重点人群中的乙型肝炎、丙型肝炎和艾滋病毒流行情况以及相关的性和物质使用风险行为:来自七个城市横断面调查的结果(2017 年)。
BMC Infect Dis. 2020 Sep 7;20(1):655. doi: 10.1186/s12879-020-05359-y.
4
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.尽管在艾滋病毒感染者中普遍获得直接作用抗病毒治疗后仍存在持续的风险,但丙型肝炎病毒再感染率较低。
AIDS. 2020 Jul 15;34(9):1347-1358. doi: 10.1097/QAD.0000000000002562.
5
HCV point-of-care screening programme and treatment options for people who use drugs in a metropolitan area of Southern Italy.意大利南部一个大都市地区针对吸毒人群的 HCV 即时检测筛查项目和治疗选择。
Liver Int. 2019 Oct;39(10):1845-1851. doi: 10.1111/liv.14166. Epub 2019 Jul 10.
6
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.加拿大注射毒品的艾滋病毒-丙型肝炎病毒合并感染者在丙型肝炎病毒预防和护理方面存在的差距。
Int J Drug Policy. 2022 May;103:103627. doi: 10.1016/j.drugpo.2022.103627. Epub 2022 Feb 24.
7
Implementation of a decentralized hepatitis C care pathway for people who use drugs in Dutch addiction care. Study protocol for the Hepatitis C: chain of addiction care (CAC) project.在荷兰成瘾护理中为使用毒品的人群实施去中心化丙型肝炎护理途径。丙型肝炎:成瘾护理链(CAC)项目研究方案。
Addict Sci Clin Pract. 2022 Nov 30;17(1):67. doi: 10.1186/s13722-022-00350-1.
8
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study.在普遍使用直接抗病毒药物治疗背景下注射吸毒者中丙型肝炎病毒感染状况的知晓情况:ETHOS 参与研究。
Int J Drug Policy. 2022 Dec;110:103876. doi: 10.1016/j.drugpo.2022.103876. Epub 2022 Oct 12.
9
HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study.西班牙马德里的吸毒者中进行 HIV 筛查和接受治疗的情况:一项前瞻性研究。
Infect Dis Poverty. 2021 Aug 19;10(1):111. doi: 10.1186/s40249-021-00894-5.
10
Increased case-finding and uptake of direct-acting antiviral treatment essential for micro-elimination of hepatitis C among people living with HIV: a national record linkage study.提高病例发现率和直接抗病毒治疗的接受率对于在艾滋病毒感染者中实现丙型肝炎的微消除至关重要:一项全国性的记录链接研究。
HIV Med. 2021 May;22(5):334-345. doi: 10.1111/hiv.13032. Epub 2020 Dec 17.

本文引用的文献

1
An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.一种适用于普通人群中靶向丙型肝炎病毒检测的易于实施的风险评分。
Microbiol Spectr. 2022 Apr 27;10(2):e0228621. doi: 10.1128/spectrum.02286-21. Epub 2022 Mar 31.
2
[HCV and infection status in HIV/AIDS cases in Yunnan province, January-June, 2020].[2020年1月至6月云南省HIV/AIDS病例中的丙型肝炎病毒(HCV)及感染状况]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Nov 10;42(11):1983-1988. doi: 10.3760/cma.j.cn112338-20210517-00406.
3
On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era.
现场检测和病例管理以改善 DAA 时代药物使用者的丙型肝炎护理:一项前瞻性、纵向、多中心研究。
BMC Public Health. 2021 Aug 20;21(1):1574. doi: 10.1186/s12889-021-11608-9.
4
Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire.在新罕布什尔州对注射吸毒者进行丙型肝炎消除建模。
JAMA Netw Open. 2021 Aug 2;4(8):e2119092. doi: 10.1001/jamanetworkopen.2021.19092.
5
Remaining challenges in HCV elimination.丙型肝炎病毒消除工作中尚存的挑战。
J Hepatol. 2021 Apr;74(4):964-965. doi: 10.1016/j.jhep.2020.11.051. Epub 2021 Feb 13.
6
Changing trends in the types of drug used and infectious disease prevalence among drug users in jiangsu province, china.江苏省吸毒者使用药物类型和传染病流行率的变化趋势。
Int J Drug Policy. 2021 Feb;88:103034. doi: 10.1016/j.drugpo.2020.103034. Epub 2020 Nov 21.
7
Influence of Social Media on Sexualized Drug Use and Chemsex Among Chinese Men Who Have Sex With Men: Observational Prospective Cohort Study.社交媒体对中国男男性行为者中性化药物使用和 Chemsex 的影响:观察性前瞻性队列研究。
J Med Internet Res. 2020 Jul 24;22(7):e17894. doi: 10.2196/17894.
8
Development and Validation of a Risk Prediction Tool to Identify People with HIV Infection Likely Not to Achieve Viral Suppression.开发和验证一种风险预测工具,以识别可能无法实现病毒抑制的 HIV 感染者。
AIDS Patient Care STDS. 2020 Apr;34(4):157-165. doi: 10.1089/apc.2019.0224.
9
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
10
Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.筛查青少年和成年人丙型肝炎病毒感染:美国预防服务工作组建议声明。
JAMA. 2020 Mar 10;323(10):970-975. doi: 10.1001/jama.2020.1123.